HG-10-102-01 [Ligand Id: 9392] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2170016
  • leucine rich repeat kinase 2/Leucine-rich repeat serine/threonine-protein kinase 2 in Human [ChEMBL: CHEMBL1075104] [GtoPdb: 2059] [UniProtKB: Q5S007]
There should be some charts here, you may need to enable JavaScript!
  • MAPK interacting serine/threonine kinase 2/MAP kinase signal-integrating kinase 2 in Human [ChEMBL: CHEMBL4204] [GtoPdb: 2105] [UniProtKB: Q9HBH9]
There should be some charts here, you may need to enable JavaScript!
  • mitogen-activated protein kinase kinase kinase 9/Mitogen-activated protein kinase kinase kinase 9 in Human [ChEMBL: CHEMBL2872] [GtoPdb: 2084] [UniProtKB: P80192]
There should be some charts here, you may need to enable JavaScript!
  • Janus kinase 2/Tyrosine-protein kinase JAK2 in Human [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
leucine rich repeat kinase 2/Leucine-rich repeat serine/threonine-protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075104] [GtoPdb: 2059] [UniProtKB: Q5S007]
GtoPdb - - 8.52 pKi 3 nM Ki J Med Chem (2012) 55: 5536-45 [PMID:22591441]
ChEMBL Inhibition of LRRK2 B 8.52 pKi 3 nM Ki J Med Chem (2012) 55: 5536-5545 [PMID:22591441]
ChEMBL Inhibition of LRRK2 using FAM-LRRKtide as substrate after 120 mins by microfluidic capillary electrophoresis assay B 8.52 pKi 3 nM Ki J Med Chem (2012) 55: 9416-9433 [PMID:22985112]
ChEMBL Inhibition of LRRK2 A2016T mutant expressed in HEK293 cells using nictide as substrate and [gamma32P]ATP after 15 mins by Cerenkov counting method B 6.81 pIC50 153.7 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
ChEMBL Inhibition of LRRK2 G2019S/A2016T mutant expressed in HEK293 cells using nictide as substrate and [gamma32P]ATP after 15 mins by Cerenkov counting method B 7.02 pIC50 95.9 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
ChEMBL Inhibition of autophosphorylation of LRRK2 in human HEK293 cells B 7.54 pIC50 29 nM IC50 J Med Chem (2012) 55: 9416-9433 [PMID:22985112]
GtoPdb Inhibition of LRRK2G2019S in vitro - 7.61 pIC50 24.3 nM IC50 chemrxiv (2022) :
ChEMBL Inhibition of LRRK2 expressed in HEK293 cells using nictide as substrate and [gamma32P]ATP after 15 mins by Cerenkov counting method B 7.69 pIC50 20.3 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
GtoPdb Inhibition of WT hLRRK2 in vitro - 7.91 pIC50 12.4 nM IC50 chemrxiv (2022) :
ChEMBL Inhibition of LRRK2 G2019S mutant expressed in HEK293 cells using nictide as substrate and [gamma32P]ATP after 15 mins by Cerenkov counting method B 8.49 pIC50 3.2 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
ChEMBL Inhibition of LRRK2 G2019S mutant (unknown origin) using biotinylated ezrin/radaxin/meosin peptide as substrate measured after 1 hr B 8.49 pIC50 3.2 nM IC50 Bioorg Med Chem Lett (2017) 27: 2520-2527 [PMID:28408230]
MAPK interacting serine/threonine kinase 2/MAP kinase signal-integrating kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4204] [GtoPdb: 2105] [UniProtKB: Q9HBH9]
ChEMBL Inhibition of MNK2 by radiometric assay B 6.22 pIC50 600 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
mitogen-activated protein kinase kinase kinase 9/Mitogen-activated protein kinase kinase kinase 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2872] [GtoPdb: 2084] [UniProtKB: P80192]
ChEMBL Inhibition of MLK1 by radiometric assay B 5.68 pIC50 2100 nM IC50 ACS Med Chem Lett (2012) 3: 658-662 [PMID:23066449]
Janus kinase 2/Tyrosine-protein kinase JAK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674]
GtoPdb - - 5.49 pKi >3200 nM Ki J Med Chem (2012) 55: 5536-45 [PMID:22591441]
ChEMBL Inhibition of JAK2 B 5.49 pKi >3200 nM Ki J Med Chem (2012) 55: 5536-5545 [PMID:22591441]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]